These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy. Fitchett D; Verma A; Eikelboom J; Madan M; Cohen E; Bell A; Dorian P Curr Opin Cardiol; 2014 Jan; 29(1):1-9. PubMed ID: 24284976 [TBL] [Abstract][Full Text] [Related]
7. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis]. Yuan C; Zhong L; Huang RC Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031 [No Abstract] [Full Text] [Related]
8. [Antithrombotic therapy and atrial fibrillation. Dual or triple therapy after acute coronary syndrome and stent?]. Zeymer U; Zahn R Herz; 2014 Nov; 39(7):814-8. PubMed ID: 25336242 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management. Deshmukh A; Hilleman DE; Del Core M; Nair CK Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218 [TBL] [Abstract][Full Text] [Related]
10. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation. Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
16. Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents. Enomoto Y; Iijima R; Tokue M; Ito N; Nagashima Y; Araki T; Yamazaki K; Utsunomiya M; Hori M; Itaya H; Shiba M; Hara H; Nakamura M; Sugi K Cardiovasc Interv Ther; 2014 Jul; 29(3):193-9. PubMed ID: 24366503 [TBL] [Abstract][Full Text] [Related]
17. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits? Asencio LA; Huang JJ; Alpert JS Am J Med; 2014 Jul; 127(7):579-85. PubMed ID: 24608021 [TBL] [Abstract][Full Text] [Related]
18. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting. Pipilis A; Lazaros G; Tsakonas G; Stefanadis C Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831 [No Abstract] [Full Text] [Related]
19. Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble. Leggio M; Fusco A; Severi P; Lombardi M; Caldarone E; D'Emidio S; Armeni M; Mereu D; Bendini MG; Mazza A Drugs; 2018 Sep; 78(13):1309-1319. PubMed ID: 30132258 [TBL] [Abstract][Full Text] [Related]